Cronyxin 50 mg/g Oral paste for horses
Cronyxin 50 mg/g Oral paste for horses
Authorised
- Flunixin meglumine
Product identification
Medicine name:
Cronyxin 50 mg/g Oral paste for horses
Cronyxin, 50 mg/g suukaudne pasta hobustele
Active substance:
- Flunixin meglumine
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Flunixin meglumine83.00milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral paste
Withdrawal period by route of administration:
-
Oral use
- Horse
-
Meat and offal15day
-
Milkno withdrawal periodNot authorised for use in animals producing milk for human consumption.
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AG90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- (ID5): 1 unspecified outer container with 12 Syringe (High Density PolyEthylene) with 33 gram(s) (396 gram(s))
- (ID4): 1 unspecified outer container with 6 Syringe (High Density PolyEthylene) with 33 gram(s) (198 gram(s))
- (ID3): 1 unspecified outer container with 3 Syringe (High Density PolyEthylene) with 33 gram(s) (99 gram(s))
- (ID2): 1 unspecified outer container with 2 Syringe (High Density PolyEthylene) with 33 gram(s) (66 gram(s))
- (ID1): 1 unspecified outer container with 1 Syringe (High Density PolyEthylene) with 33 gram(s) (33 gram(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Bimeda Animal Health Limited
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 2131
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0178/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Estonia
-
Finland
-
France
-
Ireland
-
Italy
-
Netherlands
-
Poland
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 11/03/2022
Combined File of all Documents
English (PDF)
Download Published on: 19/12/2022
How useful was this page?: